Comparative Pharmacology
Head-to-head clinical analysis: DICURIN PROCAINE versus ZESTORETIC.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DICURIN PROCAINE versus ZESTORETIC.
DICURIN PROCAINE vs ZESTORETIC
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Dicurin Procaine is a mercurial diuretic that inhibits sodium and chloride reabsorption in the proximal tubule and loop of Henle, leading to increased urine output. The procaine component provides local anesthetic effects.
Combination of lisinopril (ACE inhibitor) and hydrochlorothiazide (thiazide diuretic). Lisinopril inhibits angiotensin-converting enzyme, reducing angiotensin II formation, decreasing vasoconstriction and aldosterone secretion. Hydrochlorothiazide inhibits sodium reabsorption in distal convoluted tubule, increasing diuresis and reducing plasma volume.
50-100 mg (as procaine penicillin G) intramuscularly once daily; severe infections: 100-200 mg IM every 12-24 hours.
Zestoretic (lisinopril/hydrochlorothiazide) is available in fixed-dose combinations. Typical adult dose: 10 mg/12.5 mg, 20 mg/12.5 mg, or 20 mg/25 mg orally once daily. Maximum dose: lisinopril 80 mg/day, hydrochlorothiazide 50 mg/day.
None Documented
None Documented
Terminal elimination half-life: 0.5-1.5 hours (short-acting local anesthetic). Clinically, repeated doses may lead to accumulation if hepatic or renal impairment exists.
Lisinopril: terminal half-life approximately 12 hours (accumulation half-life 13.8 hours in patients with normal renal function). Hydrochlorothiazide: terminal half-life 5.6–14.8 hours (mean 9.6 hours).
Renal excretion of unchanged drug and metabolites: 60-80% via glomerular filtration and tubular secretion; biliary excretion <5%.
Lisinopril is excreted unchanged in urine; 100% renal elimination. Hydrochlorothiazide is excreted primarily by the kidney (≥95% as unchanged drug) via tubular secretion.
Category C
Category C
Diuretic
ACE Inhibitor + Diuretic